Letrero LED Digital Texto LED
Published by:
Merative US L.P
Description
The support of this app will be discontinued on Feb 20, 2025. Visit the App Store to download the new Micromedex mobile app
https://apps.apple.com/app/merative/id6471286555
Micromedex Drug Reference app is free to subscribers of Merative Micromedex Drug Reference online.
Access to Micromedex Drug Reference requires a password. Once you’ve downloaded the app, follow these instructions to obtain the password (which only needs to be entered once per year):
1. Login to Merative Micromedex through your online subscription.
2. Click “Mobile Application Access” near the top of the application.
3. Refer to the detailed downloading instructions, which include your password for activating the mobile app at no charge.
If you cannot locate the “Mobile Application Access” link, or have other questions related to this app, please contact support via https://merative.my.site.com/mysupport/s/micromedex-support-request.
Access the evidence-based content you rely on in Micromedex Drug Reference, anytime, anywhere, via your iPhone and iPad.
Micromedex Drug Reference provides clinical care professionals with on-the-go access to the industry’s most trusted drug information, when and where it’s needed most. Users will find peace of mind knowing the content is backed by the same thorough, unbiased editorial process as all Merative Micromedex® solutions.
Once content has been downloaded or updated an internet connection is not required, allowing for access at anytime from anywhere.
The app is part of the Merative Micromedex Medication Management apps bundle, which includes Micromedex Drug Interactions and Micromedex IV Compatibility. The trio is an excellent solution to your on-the-go medication management needs.
Micromedex Drug Reference app contains concise information on 4500+ search terms, covering common needs such as:
• Adult and pediatric dosage
• Adverse effects (separated into “common” and “serious”)
• Drug interactions
As well as:
• Administration
• Black box warnings
• Breast feeding
• Common trade names
• Contraindications
• Dose adjustments
• Generic names, including selected combination products
• How supplied
• Indications (differentiated as “FDA labeled” and “non-FDA labeled”)
• Mechanism of action
• Monitoring
• Precautions
• Pregnancy category
• Therapeutic class
Hide
Show More...
https://apps.apple.com/app/merative/id6471286555
Micromedex Drug Reference app is free to subscribers of Merative Micromedex Drug Reference online.
Access to Micromedex Drug Reference requires a password. Once you’ve downloaded the app, follow these instructions to obtain the password (which only needs to be entered once per year):
1. Login to Merative Micromedex through your online subscription.
2. Click “Mobile Application Access” near the top of the application.
3. Refer to the detailed downloading instructions, which include your password for activating the mobile app at no charge.
If you cannot locate the “Mobile Application Access” link, or have other questions related to this app, please contact support via https://merative.my.site.com/mysupport/s/micromedex-support-request.
Access the evidence-based content you rely on in Micromedex Drug Reference, anytime, anywhere, via your iPhone and iPad.
Micromedex Drug Reference provides clinical care professionals with on-the-go access to the industry’s most trusted drug information, when and where it’s needed most. Users will find peace of mind knowing the content is backed by the same thorough, unbiased editorial process as all Merative Micromedex® solutions.
Once content has been downloaded or updated an internet connection is not required, allowing for access at anytime from anywhere.
The app is part of the Merative Micromedex Medication Management apps bundle, which includes Micromedex Drug Interactions and Micromedex IV Compatibility. The trio is an excellent solution to your on-the-go medication management needs.
Micromedex Drug Reference app contains concise information on 4500+ search terms, covering common needs such as:
• Adult and pediatric dosage
• Adverse effects (separated into “common” and “serious”)
• Drug interactions
As well as:
• Administration
• Black box warnings
• Breast feeding
• Common trade names
• Contraindications
• Dose adjustments
• Generic names, including selected combination products
• How supplied
• Indications (differentiated as “FDA labeled” and “non-FDA labeled”)
• Mechanism of action
• Monitoring
• Precautions
• Pregnancy category
• Therapeutic class
Letrero LED Digital Texto LED FAQ
-
Is Letrero LED Digital Texto LED free?
Yes, Letrero LED Digital Texto LED is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Letrero LED Digital Texto LED legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Letrero LED Digital Texto LED cost?
Letrero LED Digital Texto LED is free.
-
What is Letrero LED Digital Texto LED revenue?
To get estimated revenue of Letrero LED Digital Texto LED app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Türkiye yet.
Ratings History
Letrero LED Digital Texto LED Reviews
App doesn't have any reviews yet
Keywords
Letrero LED Digital Texto LED Competitors
Micromedex Drug Reference Installs
Last 30 days
Micromedex Drug Reference Revenue
Last 30 daysLetrero LED Digital Texto LED Revenue and Downloads
Gain valuable insights into Micromedex Drug Reference performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Merative US L.P
- Languages
- English
- Recent release
- 3.0.8 (9 months ago )
- Released on
- Aug 14, 2013 (12 years ago )
- Last Updated
- 4 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.